An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family

Journal of General Physiology

Volumn 126, Issue 1, 2005, Pages 41-53

  McLaughlin, Stuart ^a   Smith, Steven O ^b   Hayman, Michael J ^b   Murray, Diana ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALMODULIN; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOTRANSFERASE;

ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CELL MEMBRANE; CELL STRAIN COS1; CENTRIFUGATION; ELECTRICITY; ENERGY TRANSFER; ENZYME INHIBITION; FLUORESCENCE CORRELATION SPECTROSCOPY; MEMBRANE BINDING; MODEL; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN DOMAIN;

ANIMALS; BINDING SITES; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; COMPUTER SIMULATION; COS CELLS; ELECTROSTATICS; ENZYME ACTIVATION; ENZYME INHIBITORS; LIPID BILAYERS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; MOLECULAR MOTOR PROTEINS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 22244449320     PISSN: 00221295     EISSN: None     Source Type: Journal    
DOI: 10.1085/jgp.200509274     Document Type: Article

References (79)

1. Aifa, S., K. Johansen, U.K. Nilsson, B. Liedberg, I. Lundstrom, and S.P.S. Svensson. 2002. Interactions between the juxtamembrane domain of the EGFR and calmodulin measured by surface plasmon resonance. Cell. Signal. 14:1005-1013.
2. Aifa, S., J. Aydin, G. Nordvall, I. Lundstrom, S.P.S. Svensson, and O. Hermanson. 2005. A basic peptide within the juxtamembrane region is required for EGF receptor dimerization. Exp. Cell Res. 302: 108-114.
3. Arbuzova, A., J. Wang, D. Murray, J. Jacob, D.S. Cafiso, and S. McLaughlin. 1997. Kinetics of interaction of the myristoylated alanine-rich C kinase substrate, membranes, and calmodulin. J. Biol. Chem. 272:27167-27177.
4. Arbuzova, A., D. Murray, and S. McLaughlin. 1998. MARCKS, membranes and calmodulin: kinetics of their interaction. Biochim. Biophys. Acta. 1376:369-379.
5. Arbuzova, A., L. Wang, J. Wang, G. Hangyàs-Mihàlynè, D. Murray, B. Honig, and S. McLaughlin. 2000. Membrane binding of peptides containing both basic and aromatic residues. Biochemistry. 39:10330-10339.
6. Bezzerides, V.J., I.S. Ramsey, S. Kotecha, A. Greka, and D.E. Clapham. 2004. Rapid vesicular translocation and insertion of TRP channels. Nat. Cell Biol. 6:709-720.
7. 2+. Cell Calcium. 35:415-425.
8. Blobel, C.P. 2005. Adams: key components in EGFR signaling and development. Nat. Rev. Mol. Cell Biol. 6:32-43.
9. Blume-Jensen, P., and T. Hunter. 2001. Oncogenic kinase signalling. Nature. 411:355-365.
10. Burgess, A.W., H.-S. Cho, C. Eigenbrot, K.M. Ferguson, T.P.J. Garrett, D.J. Leahy, M.A. Lemmon, M.X. Sliwkowski, C.W. Ward, and S. Yokoyama. 2003. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol. Cell. 12:541-552.
11. Carpenter, G. 2003. ErbB-4: mechanism of action and biology. Exp. Cell Res. 284:66-77.
12. Carpenter, G., L. King Jr., and S. Cohen. 1979. Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor. J. Biol. Chem. 254:4884-4891.
13. Chen, X., and M.D. Resh. 2002. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J. Biol. Chem. 277:49631-49637.
14. Cheyette, T.E., and D.J. Gross. 1991. Epidermal growth factor-stimulated calcium ion transients in individual A431 cells: initiation kinetics and ligand concentration dependence. Cell Regul. 2:827-840.
15. Couchet, C., G.N. Gill, J. Meisenhelder, J.A. Cooper, and T. Hunter. 1984. C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem. 259:2553-2558.
16. Countaway, J.L., P. McQuilkin, N. Girones, and R.J. Davis. 1990. Multisite phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 265:3407-3416.
17. Davis, R.J., N. Gironès, and M. Faucher. 1988. Two alternative mechanisms control the interconversion of functional states of the epidermal growth factor receptor. J. Biol. Chem. 263:5373-5379.
18. Ferguson, K.M. 2004. Active and inactive conformations of the epidermal growth factor receptor. Biochem. Soc. Trans. 32:742-745.
19. Ferguson, K.M., M.B. Berger, J.M. Mendrola, H.S. Cho, D.J. Leahy, and M.A. Lemmon. 2003. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol. Cell. 11:507-517.
20. Friedman, B., J. van Amsterdam, H. Fujiki, and M.R. Rosner. 1989. Phosphorylation at threonine-654 is not required for negative regulation of the epidermal growth factor receptor by non-phorbol tumor promoters. Proc. Natl. Acad. Sci. USA. 86:812-816.
21. 2 on phospholipid membranes by basic/aromatic regions of proteins. Biophys. J. 86:2188-2207.
22. Gotoh, N., A. Tojo, M. Hino, Y. Yazaki, and M. Shibuya. 1992. A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor. Biochem. Biophys. Res. Commun. 186:768-774.
23. Gschwind, A., E. Zwick, N. Prenzel, M. Leserer, and A. Ullrich. 2001. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene. 20:1594-1600.
24. Gschwind, A., O.M. Fischer, and A. Ullrich. 2004. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer. 4:361-370.
25. Hendriks, B.S., G. Orr, A. Well, H.S. Wiley, and D.A. Lauffenburger. 2005. Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells. J. Biol. Chem. 280:6157-6169.
26. Holthuis, J.C.M., and T.P. Levine. 2005. Lipid traffic: floppy drives and a superhighway. Nat. Rev. Mol. Cell Biol. 6:209-220.
27. Hubbard, S.R. 2004. Juxtamembrane autoinhibition in receptor tyrosine kinases. Nat. Rev. Mol. Cell Biol. 5:464-470.
28. Hubbard, S.R., and J.H. Till. 2000. Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69:373-398.
29. 2+ signaling in A431 cells. Mol. Pharmacol. 40: 254-262.
30. Hunter, T., N. Ling, and J.A. Cooper. 1984. Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature. 311:480-483.
31. Huse, M., and J. Kuriyan. 2002. The conformational plasticity of protein kinases. Cell. 109:275-282.
32. Ichinos, J., M. Murata, T. Yanagida, and Y. Sako. 2004. EGF signaling amplification induced by dynamic clustering of EGFR. Biochem. Biophys. Res. Commun. 324:1143-1149.
33. Jorissen, R.N., F. Walker, N. Pouliot, T.P.J. Garrett, C.W. Ward, and A.W. Burgess. 2003. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res. 284:31-53.
34. Kholodenko, B.N., O.V. Demin, G. Moehren, and J.B. Hoek. 1999. Quantification of short term signaling by the epidermal growth factor receptor. J. Biol. Chem. 274:30169-30181.
35. Kim, S.A., K.G. Heinze, M.N. Waxham, and P. Schwille. 2004. Intracellular calmodulin availability accessed with two-photon crosscorrelation. Proc. Natl. Acad. Sci. USA. 101:105-110.
36. King, C.R., I. Borrello, L. Porter, P. Comoglio, and J. Schlessinger. 1989. Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock. Oncogene. 4:13-18.
37. Klapper, L.N., M.H. Kirschbaum, M. Sela, and Y. Yarden. 2000. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv. Cancer Res. 77:25-79.
38. Landau, M., S.J. Fleishman, and N. Ben-Tal. 2004. A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains. Structure (Camb.). 12:2265-2275.
39. Li, H., M.J. Ruano, and A. Villalobo. 2004a. Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. FEBS Lett. 559:175-180.
40. Li, H., J. Sanchez-Torres, A. Del Carpio, V. Salas, and A. Villalobo. 2004b. The ErebB2/Neu/HER2 receptor is a new calmodulinbinding protein. Biochem. J. 381:257-266.
41. 2+ channels through an inositol 1,4,5-trisphosphate-independent pathway in human glomerular mesangial cells. J. Biol. Chem. 279:4570-4577.
42. Martin-Nieto, J., and A. Villalobo. 1998. The human epidermal growth factor receptor contains a juxtamembrane calmodulin-binding site. Biochemistry. 37:227-236.
43. 1-mediated activation of protein tyrosine phosphatase TCPTP. Nat. Cell Biol. 7:78-85.
44. Matsuda, M., H.F. Paterson, R. Rodriguez, A.C. Fensome, M.V. Ellis, K. Swann, and M. Katan. 2001. Real time fluorescence imaging of PLCγ translocation and its interaction with the epidermal growth factor receptor. J. Cell Biol. 153:599-612.
45. McLaughlin, S. 1989. The electrostatic properties of membranes. Annu. Rev. Biophys. Biophys. Chem. 18:113-136.
46. Moehren, G., N. Markevich, O. Demin, A. Kiyatkin, I. Goryanin, J.B. Hoek, and B.N. Kholodenko. 2002. Temperature dependence of the epidermal growth factor receptor signaling network can be accounted for by a kinetic model. Biochemistry. 41:306-320.
47. 2+/calmodulindependent transactivation of epidermal growth factor receptor. Circ. Res. 82:1338-1348.
48. Murray, D., A. Arbuzova, B. Honig, and S. McLaughlin. 2002. The role of electrostatic and nonpolar interactions in the associations of peripheral proteins with membranes. Curr. Top. Membranes. 52: 277-307.
49. Nojiri, S., and J.B. Hoek. 2000. Suppression of epidermal growth factor-induced phospholipase C activation associated with actin rearrangement in rat hepatocytes in primary culture. Hepatology. 32:947-957.
50. Ogiso, H., R. Ishitani, O. Nureki, S. Fukai, M. Yamanaka, J.H. Kim, K. Saito, A. Sakamoto, M. Inoue, M. Shirouzu, and S. Yokoyama. 2002. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell. 110:775-787.
51. Osawa, M., M.B. Swindells, J. Tanikawa, T. Tanaka, T. Mase, T. Furuya, and M. Ikura. 1998. Solution structure of calmodulin-W-7 complex: the basis of diversity in molecular recognition. J. Mol. Biol. 276:165-176.
52. Paez, J.G., A.J. Pasi, J.C. Lee, S. Tracy, H. Grenlich, S. Gabriel, P. Herman, F.J. Kaye, N. Lindeman, T.J. Boggon, et al. 2004. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 304:1497-1500.
53. Papin, J.A., T. Hunter, B.O. Palsson, and S. Subramaniam. 2005. Reconstruction of cellular signaling networks and analysis of their properties. Nat. Rev. Mol. Cell Biol. 6:99-111.
54. 2+ increase and alkalinization correlate with epidermalgrowth-factor-induced cell proliferation. Biochem. J. 254:223-228.
55. Persechini, A., and P.M. Stemmer. 2002. Calmodulin is a limiting factor in the cell. Trends Cardiovasc. Med. 12:32-37.
56. Prenzel, N., E. Zwick, H. Daub, M. Leserer, R. Abraham, C. Wallasch, and A. Ullrich. 1999. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402:884-888.
57. Rakhilin, S.V., P.A. Olson, A. Nishi, N.N. Starkova, A.A. Fienberg, A.C. Nairn, D.J. Surmeier, and P. Greengard. 2004. A network of control mediated by regulator of calcium/calmodulin-dependent signaling. Science. 306:698-701.
58. Reynolds, A.R., C. Tischeer, P.J. Verveer, O. Rocks, and P.I.H. Bastiaens. 2003. EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation. Nat. Cell Biol. 5:447-453.
59. 2 in HaCaT cells by an epidermal growth factor receptor-mediated process. Cell. Signal. 14:839-848.
60. Roepstorff, K., P. Thomsen, K. Samndvig, and B. van Deurs. 2002. Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding. J. Biol. Chem. 277:18954-18960.
61. Rusu, L., A. Gambhir, S. McLaughlin, and J. Radler. 2004. Fluorescence correlation spectroscopy studies of peptide and protein binding to phospholipid vesicles. Biophys. J. 87:1044-1053.
62. Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell. 103:211-225.
63. Schlessinger, J. 2003. Signal transduction. Autoinhibition control. Science. 300:750-752.
64. Shapiro, M.S. 2004. Why biophysicists make models: quantifying modulation of the M current. J. Gen. Physiol. 123:657-662.
65. Simons, K., and W.L.C. Vaz. 2004. Model systems, lipid rafts, and cell membranes. Annu. Rev. Biophys. Biomol. Struct. 33:269-295.
66. Stamos, J., M.X. Sliwkowski, and C. Eigenbrot. 2002. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 277:46265-46272.
67. Sordella, R., D.W. Bell, D.A. Haber, and J. Settleman. 2004. Ge-fitinib-sensitizing EGFR mutations in lung cancer activate antiapoptotic pathways. Science. 305:1163-1167.
68. Tonks, N. 2003. PTP1B: from the sidelines to the front lines! FEBS Lett. 546:140-148.
69. Ullrich, A., L. Coussens, J.S. Hayflick, T.S. Dull, A. Gray, A.W. Tam, J. Lee, Y. Yarden, T.A. Liberman, J. Schlessinger, et al. 1984. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature. 309:418-425.
70. Yarden, Y., and M.X. Sliwkowski. 2001. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2:127-137.
71. Wang, J., A. Gambhir, G. Hangyás-Mihályné, D. Murray, U. Golebiewska, and S. McLaughlin. 2002. Lateral sequestration of phosphatidylinositol 4,5-bisphosphate by the basic effector domain of myristoylated alanine-rich C kinase substrate is due to nonspecific electrostatic interactions. J. Biol. Chem. 277:34401-34412.
72. 1 to the plasma membrane and endosomes. Exp. Cell Res. 267:28-36.
73. 1 translocation and activation by its SH2 and PH domains. Traffic. 4:618-630.
74. Welsh, J.G., G.N. Gill, M.G. Rosenfeld, and A. Wells. 1991. A negative feedback loop attenuates EGF-induced morphological changes. J. Cell Biol. 114:533-543.
75. Westhover, E.J., D.F. Cover, H.L. Brockman, R.E. Brown, and L.J. Pike. 2003. Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. J. Biol. Chem. 278:51125-51133.
76. Wiley, H.S., S.Y. Shvartsman, and D.A. Lauffenburger. 2003. Computational modeling of the EGF-receptor system: a paradigm for systems biology. Trends Cell Biol. 13:43-50.
77. Wong, W., and J.D. Scott. 2004. AKAP signaling complexes: focal points in space and time. Nat. Rev. Mol. Cell Biol. 5:959-970.
78. Wood, E.R., A.T. Truesdale, O.B. McDonald, D. Yuan, A. Hassell, S.H. Dickerson, B. Ellis, C. Pennisi, E. Horne, K. Lackey, et al. 2004. A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib). Cancer Res. 64:6652-6659.
79. Zwick, E., P.O. Hackel, N. Prenzel, and A. Ullrich. 1999. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol. Sci. 20:408-412.